Soil salinization is a major and increasing problem adversely impacting plant growth and crop production. Accordingly, coping with this problem has become a central topic in agriculture. In this study, we address this issue by evaluating the potential effectiveness of two bacterial species, Azospirillum brasilense and Paenibacillus dendritiformis, in enhancing growth and yield of melon and tomato plants under salinity stress. In vitro laboratory experiments indicated that these bacteria can efficiently colonize plant roots, and increase root length (25–33%) and root biomass (46–210%) of three melon plant varieties under saline stress. Similarly, greenhouse experiments showed that these bacteria significantly induced root (78–102%) and shoot weights (37–57%) of the three melon varieties irrigated with saline water. Tomato plants grown under the same conditions did not exhibit growth deficiency upon exposure to the saline stress and their growth was not enhanced in response to bacterial inoculation. Interestingly, saline-stressed melon plants inoculated with P. dendritiformis and A. brasilense exhibited lower total antioxidant activity compared to un-inoculated plants (80% vs. 60% of DPPH radical scavenging activity, respectively), suggesting that the inoculated plants experienced lower stress levels. These positive effects were further manifested by an increase of 16% in the crop yield of melon plants grown in the field under standard agricultural fertilization practices, but irrigated with saline water. Overall, these results demonstrate the beneficial effects of two plant-growth-promoting rhizobacteria, which can significantly alleviate the negative outcome of salt stress.

Copper is known to have toxic effects on bacterial growth. This study aimed to determine the influence of copper ions on Oleidesulfovibrio alaskensis G20 biofilm formation in a lactate-C medium supplemented with variable copper ion concentrations. OA G20, when grown in media supplemented with high copper ion concentrations of 5, 15, and 30 µM, exhibited inhibited growth in its planktonic state. Conversely, under similar copper concentrations, OA G20 demonstrated enhanced biofilm formation on glass coupons. Microscopic studies revealed that biofilms exposed to copper stress demonstrated a change in cellular morphology and more accumulation of carbohydrates and proteins than controls. Consistent with these findings, sulfur (dsrA, dsrB, sat, aprA) and electron transport (NiFeSe, NiFe, ldh, cyt3) genes, polysaccharide synthesis (poI), and genes involved in stress response (sodB) were significantly upregulated in copper-induced biofilms, while genes (ftsZ, ftsA, ftsQ) related to cellular division were negatively regulated compared to controls. These results indicate that the presence of copper ions triggers alterations in cellular morphology and gene expression levels in OA G20, impacting cell attachment and EPS production. This adaptation, characterized by increased biofilm formation, represents a crucial strategy employed by OA G20 to resist metal ion stress.

Type 2 diabetes mellitus (T2DM), responsible for most diabetes cases recorded worldwide, increases the risk of chronic wounds and amputation. Patients with T2DM appear to be more susceptible to delayed wound healing due to their treatment adherence. This review explores the specifics of polypharmacy, side effects, possible drug interactions and the importance of medication adherence for therapeutic efficacy. We discuss the effects of anti-diabetes medications on wound healing as well as the role that biofilms and microbial infections play in diabetic wounds. Inconsistent use of medications can lead to poor glycaemic control, which negatively affects the healing process of diabetic foot ulcers. Managing chronic wounds represents a substantial portion of healthcare expenditures. Biofilm-associated infections are difficult for the immune system to treat and respond inconsistently to antibiotics as these infections are slow growing and persistent. Additionally, we emphasize the critical role pharmacists play in enhancing patient adherence and optimizing diabetes treatment by offering comprehensive coverage of drugs associated with problems related to pharmacological therapy in type 2 diabetes.